Alzheimer’s disease

17 Million senior citizens may get affected of Alzheimer’s Diseases by 2036 Early detection of Alzheimer Diseases is the only solution for better treatment

Mumbai, September 24, 2024: Alzheimer's disease is a condition where the brain starts to shrink, and the brain cells start…

2 months ago

Early symptoms of Alzheimer’s disease

Dr Neeraj Balaini, Consultant -Neurology, Aster RV Hospital Memory loss is the most common symptom of Alzheimer's disease. However, sometimes…

1 year ago

Alzheimer’s care during covid-19 outbreak

By Dr. M. Jayasree,  Consultant Neurologist  KIMS Hospitals, Sec-bad. World Alzheimer’s Day on 21st September 2020 Alzheimer's disease (AD) is a…

4 years ago

Understanding the link between hearing loss and dementia

National, September 17, 2020: Hearing loss has been shown to be linked to dementia in epidemiological studies and may be…

4 years ago

Eisai: Initiation of New Phase III Clinical Study (Ahead 3-45) of ban2401 Preclinical (Asymptomatic) Alzheimer’s Disease

New Delhi, July 14, 2020: The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd., and Biogen Inc. announced today that…

4 years ago

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease

Independent data monitoring committee advises aducanumab unlikely to meet primary endpoints, leading to decision to discontinue the trials Cambridge, March…

6 years ago

Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab

Data Includes Additional Analyses of Long-Term Extension Phase 1b Study With Titration Cohort at 36 Months and Fixed-Dose Cohorts at…

6 years ago

Suven Life Sciences secures Product Patents in China and Sri Lanka

New Delhi, January 20, 2018: Suven Life SciencesBSE -0.92 % has secured a product patent each from China and Sri Lankacorresponding to the new chemical…

7 years ago